Bethlehem A Lulseged, Malini S Ramaiyer, Rachel Michel, Eslam E Saad, Bulent Ozpolat, Mostafa A Borahay
Nanomedicine has revolutionized drug delivery in the last two decades. Nanoparticles appear to be a promising drug delivery platform in the treatment of various gynecological disorders including uterine leiomyoma, endometriosis, polycystic ovarian syndrome (PCOS), and menopause. Nanoparticles are tiny (mean size < 1000 nm), biodegradable, biocompatible, non-toxic, safe, and relatively inexpensive materials commonly used in imaging and the drug delivery of various therapeutics, such as chemotherapeutics, small molecule inhibitors, immune mediators, protein peptides and non-coding RNA...
May 1, 2024: Molecules: a Journal of Synthetic Chemistry and Natural Product Chemistry